Contributions to evaluation of regulatory processes: the case of electronic cigarettes in Brazil: Vigil Sanit Debate, Rio de Janeiro, 2024, v.12: e02213 | Published on: 20/02/2024
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Vigilância Sanitária em Debate |
Texto Completo: | https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2213 |
Resumo: | Introduction: The Electronic Nicotine Delivery Systems, represented by electronic cigarettes (e-cigarettes), are object of a global dispute in public health. In Brazil, they are forbidden but this interdiction is currently under a debate steered by the Brazilian Health Regulatory Agency (ANVISA, by its acronym in Portuguese). Objective: Characterize the regulatory model of ANVISA, in the case of e-cigarettes, and debate its implications for evaluations that have the regulatory process as object. Method: The documental research supported the timeline construction entailing publications about the regulatory process in ANVISA’s website, from 2009 to 2023. Results: The timeline presents the critical events that lead to consequences and reconfiguration of the analyzed process. Besides 31 news stories, 10 normative and non-normative publications compose the process. 2019 was the year with most publications, followed by 2022 and 2018. The Resolution of the Collegiate Board (RDC, by its acronym in Portuguese) n° 46/2009 was the first ANVISA opinion, prohibited the commerce, import and marketing of the devices. In 2019, the topic was included in the Regulatory Agenda based on a new regulatory model that promoted social participation. During the regulatory process, diverse stakeholders took their stances around the RDC, and started to signal a flexible opinion in face of new evidence. Conclusions: The Brazilian case, which includes diverse stakeholders and interests, contributes to the identification of approaches that allow exploring the regulatory processes as evaluation objects, re-signifying as a devices network that emerge from strategic crises. |
id |
FIOCRUZ-9_60023e4c543d301798593aa5add80787 |
---|---|
oai_identifier_str |
oai:ojs.visaemdebate.incqs.fiocruz.br:article/2213 |
network_acronym_str |
FIOCRUZ-9 |
network_name_str |
Vigilância Sanitária em Debate |
repository_id_str |
|
spelling |
Contributions to evaluation of regulatory processes: the case of electronic cigarettes in Brazil: Vigil Sanit Debate, Rio de Janeiro, 2024, v.12: e02213 | Published on: 20/02/2024Contribuições para avaliação de processos regulatórios: o caso dos cigarros eletrônicos no Brasil: Vigil Sanit Debate, Rio de Janeiro, 2024, v.12: e02213| Publicado em: 20/02/2024Avaliação de Processos Regulatórios em SaúdeRegulação e Fiscalização em SaúdeSistemas Eletrônicos de Liberação de NicotinaAgência Nacional de Vigilância SanitáriaHealth Regulatory Processes EvaluationHealth Care Coordination and MonitoringElectronic Nicotine Delivery SystemsBrazilian Health Surveillance AgencyIntroduction: The Electronic Nicotine Delivery Systems, represented by electronic cigarettes (e-cigarettes), are object of a global dispute in public health. In Brazil, they are forbidden but this interdiction is currently under a debate steered by the Brazilian Health Regulatory Agency (ANVISA, by its acronym in Portuguese). Objective: Characterize the regulatory model of ANVISA, in the case of e-cigarettes, and debate its implications for evaluations that have the regulatory process as object. Method: The documental research supported the timeline construction entailing publications about the regulatory process in ANVISA’s website, from 2009 to 2023. Results: The timeline presents the critical events that lead to consequences and reconfiguration of the analyzed process. Besides 31 news stories, 10 normative and non-normative publications compose the process. 2019 was the year with most publications, followed by 2022 and 2018. The Resolution of the Collegiate Board (RDC, by its acronym in Portuguese) n° 46/2009 was the first ANVISA opinion, prohibited the commerce, import and marketing of the devices. In 2019, the topic was included in the Regulatory Agenda based on a new regulatory model that promoted social participation. During the regulatory process, diverse stakeholders took their stances around the RDC, and started to signal a flexible opinion in face of new evidence. Conclusions: The Brazilian case, which includes diverse stakeholders and interests, contributes to the identification of approaches that allow exploring the regulatory processes as evaluation objects, re-signifying as a devices network that emerge from strategic crises.Introdução: Os dispositivos eletrônicos para fumar, principalmente representados pelos cigarros eletrônicos, se destacam como objetos de disputa global em saúde pública. No Brasil, eles estão proibidos, mas esta interdição está sendo discutida pela Agência Nacional de Vigilância Sanitária (Anvisa). Objetivo: Caracterizar o modelo regulatório da Anvisa, no caso dos cigarros eletrônicos, e discutir suas implicações para avaliações que tenham o processo regulatório como objeto. Método: A pesquisa documental subsidiou a elaboração de linha do tempo, baseando-se em publicações relacionadas ao processo regulatório em sítio eletrônico da Anvisa, entre 2009 e 2023. Resultados: A linha do tempo apresenta os eventos críticos que presumidamente geraram consequências e levaram a uma reconfiguração do processo estudado. Além de 31 notícias, foram identificadas dez publicações normativas e não normativas que integram o processo. O ano de 2019 teve a maior concentração de publicações, seguido por 2022 e 2018. A Resolução da Diretoria Colegiada (RDC) no 46, de 28 de agosto de 2009, marcou a primeira manifestação da Agência, proibindo a comercialização, a importação e a propaganda dos dispositivos. Em 2019, a inclusão do tema na Agenda Regulatória se deu a partir de um novo modelo de regulação da Agência, com destaque para a incorporação de componente de participação social. Durante o processo, houve o reposicionamento de diversos atores em torno da RDC, que sinalizava a possibilidade de sua flexibilização a partir de novas evidências. Conclusões: O caso brasileiro, que inclui diversos atores e disputas de interesses, contribui para a identificação de abordagens que permitam explorar os processos regulatórios como avaliandos, ressignificando como uma rede de dispositivos que emergem de crises estratégicas.Instituto Nacional de Controle de Qualidade em Saúde2024-02-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/221310.22239/2317-269x.02213Health Surveillance under Debate: Society, Science & Technology ; v. 12 (2024) | Continuous publication; 1-11Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; v. 12 (2024) | Publicación continua; 1-11Vigil Sanit Debate, Rio de Janeiro; v. 12 (2024) | Publicação contínua; 1-112317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2213/1607Copyright (c) 2024 Cesar Luiz Silva Junior, Elizabeth Moreira dos Santos, Gisela Cordeiro Pereira Cardoso (Autor)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva Junior, Cesar LuizMoreira dos Santos, ElizabethCordeiro Pereira Cardoso, Gisela2024-03-15T19:24:14Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/2213Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2024-03-15T19:24:14Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Contributions to evaluation of regulatory processes: the case of electronic cigarettes in Brazil: Vigil Sanit Debate, Rio de Janeiro, 2024, v.12: e02213 | Published on: 20/02/2024 Contribuições para avaliação de processos regulatórios: o caso dos cigarros eletrônicos no Brasil: Vigil Sanit Debate, Rio de Janeiro, 2024, v.12: e02213| Publicado em: 20/02/2024 |
title |
Contributions to evaluation of regulatory processes: the case of electronic cigarettes in Brazil: Vigil Sanit Debate, Rio de Janeiro, 2024, v.12: e02213 | Published on: 20/02/2024 |
spellingShingle |
Contributions to evaluation of regulatory processes: the case of electronic cigarettes in Brazil: Vigil Sanit Debate, Rio de Janeiro, 2024, v.12: e02213 | Published on: 20/02/2024 Silva Junior, Cesar Luiz Avaliação de Processos Regulatórios em Saúde Regulação e Fiscalização em Saúde Sistemas Eletrônicos de Liberação de Nicotina Agência Nacional de Vigilância Sanitária Health Regulatory Processes Evaluation Health Care Coordination and Monitoring Electronic Nicotine Delivery Systems Brazilian Health Surveillance Agency |
title_short |
Contributions to evaluation of regulatory processes: the case of electronic cigarettes in Brazil: Vigil Sanit Debate, Rio de Janeiro, 2024, v.12: e02213 | Published on: 20/02/2024 |
title_full |
Contributions to evaluation of regulatory processes: the case of electronic cigarettes in Brazil: Vigil Sanit Debate, Rio de Janeiro, 2024, v.12: e02213 | Published on: 20/02/2024 |
title_fullStr |
Contributions to evaluation of regulatory processes: the case of electronic cigarettes in Brazil: Vigil Sanit Debate, Rio de Janeiro, 2024, v.12: e02213 | Published on: 20/02/2024 |
title_full_unstemmed |
Contributions to evaluation of regulatory processes: the case of electronic cigarettes in Brazil: Vigil Sanit Debate, Rio de Janeiro, 2024, v.12: e02213 | Published on: 20/02/2024 |
title_sort |
Contributions to evaluation of regulatory processes: the case of electronic cigarettes in Brazil: Vigil Sanit Debate, Rio de Janeiro, 2024, v.12: e02213 | Published on: 20/02/2024 |
author |
Silva Junior, Cesar Luiz |
author_facet |
Silva Junior, Cesar Luiz Moreira dos Santos, Elizabeth Cordeiro Pereira Cardoso, Gisela |
author_role |
author |
author2 |
Moreira dos Santos, Elizabeth Cordeiro Pereira Cardoso, Gisela |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Silva Junior, Cesar Luiz Moreira dos Santos, Elizabeth Cordeiro Pereira Cardoso, Gisela |
dc.subject.por.fl_str_mv |
Avaliação de Processos Regulatórios em Saúde Regulação e Fiscalização em Saúde Sistemas Eletrônicos de Liberação de Nicotina Agência Nacional de Vigilância Sanitária Health Regulatory Processes Evaluation Health Care Coordination and Monitoring Electronic Nicotine Delivery Systems Brazilian Health Surveillance Agency |
topic |
Avaliação de Processos Regulatórios em Saúde Regulação e Fiscalização em Saúde Sistemas Eletrônicos de Liberação de Nicotina Agência Nacional de Vigilância Sanitária Health Regulatory Processes Evaluation Health Care Coordination and Monitoring Electronic Nicotine Delivery Systems Brazilian Health Surveillance Agency |
description |
Introduction: The Electronic Nicotine Delivery Systems, represented by electronic cigarettes (e-cigarettes), are object of a global dispute in public health. In Brazil, they are forbidden but this interdiction is currently under a debate steered by the Brazilian Health Regulatory Agency (ANVISA, by its acronym in Portuguese). Objective: Characterize the regulatory model of ANVISA, in the case of e-cigarettes, and debate its implications for evaluations that have the regulatory process as object. Method: The documental research supported the timeline construction entailing publications about the regulatory process in ANVISA’s website, from 2009 to 2023. Results: The timeline presents the critical events that lead to consequences and reconfiguration of the analyzed process. Besides 31 news stories, 10 normative and non-normative publications compose the process. 2019 was the year with most publications, followed by 2022 and 2018. The Resolution of the Collegiate Board (RDC, by its acronym in Portuguese) n° 46/2009 was the first ANVISA opinion, prohibited the commerce, import and marketing of the devices. In 2019, the topic was included in the Regulatory Agenda based on a new regulatory model that promoted social participation. During the regulatory process, diverse stakeholders took their stances around the RDC, and started to signal a flexible opinion in face of new evidence. Conclusions: The Brazilian case, which includes diverse stakeholders and interests, contributes to the identification of approaches that allow exploring the regulatory processes as evaluation objects, re-signifying as a devices network that emerge from strategic crises. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-02-20 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion "Peer-reviewed article" "Artículo revisado por pares" "Artigo avaliado pelos pares" |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2213 10.22239/2317-269x.02213 |
url |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2213 |
identifier_str_mv |
10.22239/2317-269x.02213 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2213/1607 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
dc.source.none.fl_str_mv |
Health Surveillance under Debate: Society, Science & Technology ; v. 12 (2024) | Continuous publication; 1-11 Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; v. 12 (2024) | Publicación continua; 1-11 Vigil Sanit Debate, Rio de Janeiro; v. 12 (2024) | Publicação contínua; 1-11 2317-269X reponame:Vigilância Sanitária em Debate instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Vigilância Sanitária em Debate |
collection |
Vigilância Sanitária em Debate |
repository.name.fl_str_mv |
Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br |
_version_ |
1797042047331336192 |